Market Cap (In CNY)
8.14 Billion
Revenue (In CNY)
515.78 Million
Net Income (In CNY)
88.83 Million
Avg. Volume
2.54 Million
- Currency
- CNY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 12.47-25.99
- PE
- -
- EPS
- -
- Beta Value
- 0.58
- ISIN
- CNE100003LW0
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Dr. Xian-Ping Lu
- Employee Count
- -
- Website
- https://www.chipscreen.com
- Ipo Date
- 2019-08-12
- Details
- Shenzhen Chipscreen Biosciences Co., Ltd. engages in the research, development, and sale of original small molecule drugs. The company develops precursor compounds and original new drug product lines that are in various research phase of the specific global intellectual property protection in three areas, such as cancer, metabolic diseases, and autoimmune diseases. Shenzhen Chipscreen Biosciences Co., Ltd. was founded in 2001 and is based in Shenzhen, China.
More Stocks
-
8066Mitani Corporation
8066
-
097230
-
CMNP
-
BNTGFBrenntag SE
BNTGF
-
HAWAENGHawa Engineers Limited
HAWAENG
-
MRSKFDMG Mori Co., Ltd.
MRSKF
-
ALPHAGEOAlphageo (India) Limited
ALPHAGEO
-
TRUTruFin plc
TRU